These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17764713)

  • 1. Developmental toxicity of low generation PAMAM dendrimers in zebrafish.
    Heiden TC; Dengler E; Kao WJ; Heideman W; Peterson RE
    Toxicol Appl Pharmacol; 2007 Nov; 225(1):70-9. PubMed ID: 17764713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery.
    Yang H; Kao WJ
    Int J Nanomedicine; 2007; 2(1):89-99. PubMed ID: 17722516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
    Malik N; Wiwattanapatapee R; Klopsch R; Lorenz K; Frey H; Weener JW; Meijer EW; Paulus W; Duncan R
    J Control Release; 2000 Mar; 65(1-2):133-48. PubMed ID: 10699277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cationic polyamidoamine dendrimers' dermal toxicity in the rat skin model.
    Winnicka K; Wroblewska M; Sosnowska K; Car H; Kasacka I
    Drug Des Devel Ther; 2015; 9():1367-77. PubMed ID: 25834395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish.
    Pryor JB; Harper BJ; Harper SL
    Int J Nanomedicine; 2014; 9():1947-56. PubMed ID: 24790436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines.
    Bodewein L; Schmelter F; Di Fiore S; Hollert H; Fischer R; Fenske M
    Toxicol Appl Pharmacol; 2016 Aug; 305():83-92. PubMed ID: 27288734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers.
    Pisal DS; Yellepeddi VK; Kumar A; Palakurthi S
    Drug Deliv; 2008 Nov; 15(8):515-22. PubMed ID: 18720134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic response of zebrafish embryos to polyaminoamine (PAMAM) dendrimers.
    Oliveira E; Casado M; Faria M; Soares AM; Navas JM; Barata C; Piña B
    Nanotoxicology; 2014 Aug; 8 Suppl 1():92-9. PubMed ID: 24266889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 Antibody and RGD Peptide Conjugated Poly(amidoamine) Dendrimer for Targeted Drug Delivery of HeLa Cells.
    Mekuria SL; Debele TA; Chou HY; Tsai HC
    J Phys Chem B; 2016 Jan; 120(1):123-30. PubMed ID: 26670944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
    Madaan K; Lather V; Pandita D
    Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charge affects the oral toxicity of poly(amidoamine) dendrimers.
    Thiagarajan G; Greish K; Ghandehari H
    Eur J Pharm Biopharm; 2013 Jun; 84(2):330-4. PubMed ID: 23419816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells.
    Kannan S; Kolhe P; Raykova V; Glibatec M; Kannan RM; Lieh-Lai M; Bassett D
    J Biomater Sci Polym Ed; 2004; 15(3):311-30. PubMed ID: 15147164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branched Polymer-Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors.
    Hennig R; Veser A; Kirchhof S; Goepferich A
    Mol Pharm; 2015 Sep; 12(9):3292-302. PubMed ID: 26252154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
    Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotoxicological and teratogenic effects: A linkage between dendrimer surface charge and zebrafish developmental stages.
    Calienni MN; Feas DA; Igartúa DE; Chiaramoni NS; Alonso SDV; Prieto MJ
    Toxicol Appl Pharmacol; 2017 Dec; 337():1-11. PubMed ID: 28993268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
    Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
    Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
    Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
    J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells.
    Seib FP; Jones AT; Duncan R
    J Control Release; 2007 Feb; 117(3):291-300. PubMed ID: 17210200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.
    Naha PC; Mukherjee SP; Byrne HJ
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29443901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.